Navigation Links
DSM and DecImmune Therapeutics Sign Agreement to Develop N2 Pathway Blocking Antibody
Date:4/21/2013

f the view that success for this facility would come from leveraging both local and global demand. BPA's ongoing partnership with DSM brings a wealth of expertise to the region. Brisbane is home to sophisticated biomanufacturing technology and this contract with DecImmune bolsters the city as an internationally-recognized location for biotherapeutic development." BPA, an industry-development company owned by the Queensland State Government, put together the partnering deal with DSM Biologics, and is currently project managing the final stages of the construction of the new state-of-the-art facility in cooperation with DSM Biologics.

Financial terms were not disclosed.

DecImmune Therapeutics
DecImmune Therapeutics was founded by Michael Carroll Ph.D. (Boston Children's Hospital, Harvard Medical School), and Francis Moore Jr. MD (Brigham and Women's Hospital, Harvard Medical School).  Drs. Moore and Carroll discovered the non-muscle myosin heavy chain II ("N2") cascade that is initiated following vascular injury.  Shortly after expression of the N2 neoepitope on the cell surface in the vasculature, IgM components of the innate immune pathway bind and initiate the cascade responsible for localized tissue damage.  DecImmune is developing an antibody-based therapeutic that can prevent tissue damage and preserve organ function by inhibiting activation of the N2 neoepitope in the innate autoimmune pathway. More information can be found at www.decimmune.com.DSM – Bright Science. Brighter Living .™
Royal DSM is a global science-based company active in health, nutrition and materials. By connecting its unique competences in Life Sciences and Materials Sciences DSM is driving economic prosperity, environmental progress and social advances to create sustainable value for all stakeholders. DSM del
'/>"/>

SOURCE DSM Pharmaceutical Products
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Serina Therapeutics Announces Agreement Retaining Woodside Capital Partners as Advisor and Investment Bank
2. Serina Therapeutics Announces Worldwide Exclusive License Agreement with The Scripps Research Institute for Click Chemistry
3. Mast Therapeutics Presents MST-188 Data at 7Th Annual Sickle Cell Disease Research and Educational Symposium
4. Society for Brain Mapping and Therapeutics (SBMT) announce the formation of American Board of Brain Mapping, its 2013 award recipients and its Brain Mapping Day at the US Congress
5. Sorbent Therapeutics Initiates Phase 2b Clinical Trial of CLP-1001 for Treatment of Signs and Symptoms of Fluid Overload in Patients with Heart Failure
6. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
7. Sorrento Therapeutics, Inc. and IGDRASOL Announce Presentation on Non-Biologic Nanoparticle paclitaxel (NBN-Pac) Formulations for the Treatment of Solid Tumors at the Nanomedicine 2013 Meeting in Barcelona, Spain
8. Spencer Trask Congratulates InVivo Therapeutics on its Recent Approvals from the FDA
9. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
10. Adenosine Therapeutics Engages Needham & Company to Explore Strategic Options for Phase III Cardiac Stress Agent
11. Halozyme Therapeutics Names Matt Posard to Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... Inc. (NASDAQ: CYBX ) today announced results for ... highlights 1   Operating results for the first ... fiscal 2014, and other achievements, include: , Worldwide net ... , Strong international net sales of $13.2 million, an increase ... net product sales reached a new high of $58.8 million, ...
(Date:8/21/2014)...   Auxilium Pharmaceuticals, Inc. (NASDAQ: ... announced positive results from a randomized, double-blind Phase ... for the treatment of edematous fibrosclerotic panniculopathy (EFP), ... trial, all three doses of CCH (low (0.06mg), ... in the appearance of cellulite as measured by ...
(Date:8/20/2014)... Aug. 20, 2014  The National Association of ... results achieved by the real-time, pseudoephedrine (PSE) blocking ... Precursor Log Exchange (NPLEx), automatically blocks unlawful PSE ... meth offenders and make arrests. Data released by ... blocked the sale of more than ...
Breaking Medicine Technology:Cyberonics Reports Fiscal 2015 First Quarter Results 2Cyberonics Reports Fiscal 2015 First Quarter Results 3Cyberonics Reports Fiscal 2015 First Quarter Results 4Cyberonics Reports Fiscal 2015 First Quarter Results 5Cyberonics Reports Fiscal 2015 First Quarter Results 6Cyberonics Reports Fiscal 2015 First Quarter Results 7Cyberonics Reports Fiscal 2015 First Quarter Results 8Cyberonics Reports Fiscal 2015 First Quarter Results 9Cyberonics Reports Fiscal 2015 First Quarter Results 10Cyberonics Reports Fiscal 2015 First Quarter Results 11Cyberonics Reports Fiscal 2015 First Quarter Results 12Cyberonics Reports Fiscal 2015 First Quarter Results 13Cyberonics Reports Fiscal 2015 First Quarter Results 14Cyberonics Reports Fiscal 2015 First Quarter Results 15Cyberonics Reports Fiscal 2015 First Quarter Results 16Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 2Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 3Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 4Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 5Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 6Auxilium Pharmaceuticals, Inc. Announces Positive Data From Phase 2a Study Of CCH In Patients With Cellulite 7Kentucky's Stop-Sale System Achieves Significant Results In Battle Against Meth 2
... 27, 2011   , Strategic ... rest of the world except Nordics and the US , ... US market , Photocure ASA (OSE: PHO), a ... cancer, announces today the execution of a new commercial strategy ...
... 2011 Women ages 65-69 who break a hip are five ... the same age who don,t break a hip, according to a ... Institutes of Health and published online today in the Archives ... death risk by age group. In addition to the finding for ...
Cached Medicine Technology:Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 2Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 3Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 4Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 5Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 6Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 7Photocure Announces new Commercial Strategy for Hexvix(R), the Innovative Product for Improved Detection of Bladder Cancer 8Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 2Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 3Elderly Women Who Break a Hip at Increased Risk of Dying Within a Year 4
(Date:8/21/2014)... Pulmonary Hypertension Association goes on ... for PH patients and families to help fight ... Association – the country’s leading pulmonary hypertension ... and cure pulmonary hypertension (PH) – a disease ... the heart and can lead right to heart ...
(Date:8/21/2014)... System and The University of Texas MD Anderson Cancer ... new level of specialized breast screening at a network ... area. , Starting in late November, MD Anderson will ... for five of Memorial Hermann,s 10 breast care centers, ... Sugar Land. , Over time, the network will expand ...
(Date:8/21/2014)... a low or very low birth weight may be ... The findings, which appear in Diabetes Care , ... 2 diabetes in African American populations, which has a ... Boston University,s Slone Epidemiology Center followed more than 21,000 ... the course of 16 years, analyzing characteristics such as ...
(Date:8/21/2014)... 21, 2014 (HealthDay News) -- Black mothers are less ... here,s one possible reason why: Hospitals in neighborhoods with ... those in areas with more white residents, a U.S. ... are much less common in medical centers where the ... U.S. Centers for Disease Control and Prevention reported Thursday. ...
(Date:8/21/2014)... born at a low birth weight puts black women at ... The findings may partly explain high diabetes rates among ... low birth weight, the researchers added. Their study of ... low birth weight were 13 percent more likely to develop ... The risk of diabetes was 40 percent higher in those ...
Breaking Medicine News(10 mins):Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 2Health News:Pulmonary Hypertension Association Goes On the Road to Houston With an Education Forum for PH Patients and Families to Help Fight Rare Lung Disease 3Health News:MD Anderson and Memorial Hermann to operate breast screening network across Houston area 2Health News:Low birth weight linked to higher incidence of type 2 diabetes in African American women 2Health News:Racial Disparities in Breast-Feeding May Start With Hospitals, Study Suggests 2Health News:Low Birth Weights May Put Black Women at Risk for Diabetes 2
... quackery in the field of stem cell therapy, and propagate the ... work on improving the protocols involved in this therapy. // , ... The system would be developed under the leadership of director ... Union health secretary P K Hota., ,The decision comes as ...
... rather biological pacemaker by fusing connective tissue cells of ... pacemaker can fire on it’s own and regulate the ... way., ,Two sets of tiny electroactive 'pacing cells' ... by stimulating other cells to contract in certain sequences. ...
... of virginity affects men and women across the spectrum is included ... Sexual Experiences. This is the first book of its kind and ... most important events in life. We all read and hear the ... but it doesn't tell us what losing their virginity means to ...
... Vietnamese scientists have successfully decoded the gene of the deadly ... claimed.// If true, this news is really a shot in ... could herald in a better understanding of the variations and ... Ho Chi Minh City Pasteur Institute and the Regional Veterinary ...
... high fat, low carb diet promoted by the Harvard-trained diet ... could damage the heart., ,The study found the ... the heart's ability to store energy. , ,For the ... Research Group of Oxford University looked at 19 people who ...
... Jefferson researchers has found that kidney disease may be ... cholesterol. Studies conducted on mice have revealed that mice ... may also have high levels of a protein called ... ,A negative correlation was found between urinary albumin and ...
Cached Medicine News:Health News:Govt Keen To Propagate Stem Cell Research On Right Track 2Health News:Novel Biological Pacemaker Under Construction for Weak Hearts 2Health News:Vietnamese Scientists Unravel Genetic Code Of Bird Flu Virus 2Health News:Heart damage a consequence of Atkins’ Die 2
This catheter is intended for ultrasound examination of coronary intravascular pathology only. Intravascular ultrasound imaging is indicated in patients who are candidates for transluminal coronary i...
... is labeled with technetium 99m, MYOVIEW is ... regions of reversible myocardial ischemia in the ... and rest conditions. Imaging can begin as ... 4 hours after administration of MYOVIEW, enhancing ...
Universal Hub with Varying Blade Edge Diameters For Mounting the Blade to the Handle; Stainless Steel....
... Thallous Chloride Tl 201 Injection is supplied ... non-pyrogenic diagnostic radiopharmaceutical for intravenous administration. Each ... Chloride Tl 201 at calibration time, made ... preserved with 0.9% (v/v) benzyl alcohol. The ...
Medicine Products: